Medicine Man Technologies (Medicine Man Technologies) Debt-to-Equity : 1.88 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies Debt-to-Equity?

Medicine Man Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $34.8 Mil. Medicine Man Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $160.9 Mil. Medicine Man Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $103.9 Mil. Medicine Man Technologies's debt to equity for the quarter that ended in Mar. 2024 was 1.88.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medicine Man Technologies's Debt-to-Equity or its related term are showing as below:

SHWZ' s Debt-to-Equity Range Over the Past 10 Years
Min: -61.25 Med: 0.52 Max: 1.88
Current: 1.88

During the past 10 years, the highest Debt-to-Equity Ratio of Medicine Man Technologies was 1.88. The lowest was -61.25. And the median was 0.52.

SHWZ's Debt-to-Equity is ranked worse than
92.92% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs SHWZ: 1.88

Medicine Man Technologies Debt-to-Equity Historical Data

The historical data trend for Medicine Man Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies Debt-to-Equity Chart

Medicine Man Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.52

0.80

1.12

1.61

Medicine Man Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															1.15	1.23	1.26	1.61	1.88

Competitive Comparison of Medicine Man Technologies's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicine Man Technologies's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medicine Man Technologies's Debt-to-Equity falls into.

Medicine Man Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medicine Man Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.47	+	183.396)	/	119.292
	=	1.61

Medicine Man Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(34.766	+	160.856)	/	103.88
	=	1.88

Medicine Man Technologies (OTCPK:SHWZ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medicine Man Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicine Man Technologies (Medicine Man Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SHWZ:Canada

Address

4880 Havana Street, Suite 201, Denver, CO, USA, 80239

Website

https://www.schwazze.com

Medicine Man Technologies Inc is engaged in providing general consulting services in the cannabis industry. The company also provide seminar which includes giving guidance and tips on industry opportunities, medical and recreational market trends, cultivation methodologies and technology, extraction technology, dispensary operation, security requirements. The company's operating segment includes- Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products; Other, consisting of all other income and expenses. It generates maximum revenue from the Retail segment. The company is now operating under its new trade name, Schwazze.

Executives

Christine Jones	officer: Chief Legal Officer	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster	officer: CFO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy	director, officer: President	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck	director	625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood	director	55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji	director	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart	director	C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye	director, 10 percent owner, officer: CEO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad	director, 10 percent owner	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Brian Ruden	10 percent owner	C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239